Actively Recruiting
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Led by W.L.Gore & Associates · Updated on 2026-05-14
125
Participants Needed
2
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
CONDITIONS
Official Title
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Patient has been or is intended to be treated with the TBE Device in Zone 0 or Zone 1
- Patient is age 18 years or older at time of informed consent signature
You will not qualify if you...
- Patient unlikely to be available for defined follow-up visits at time of consent
- Patient with exclusion criteria required by local law
- Patient currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study within 12 months of enrollment
- Patient enrolled in another Gore study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Lakeland Regional Medical Center
Lakeland, Florida, United States, 33805
Actively Recruiting
2
University of Washington Medical Center
Seattle, Washington, United States, 98195
Actively Recruiting
Research Team
D
DeAnne Hart
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here